SV Life Sciences Fund IV (SVLSFIV)

SVLSF IV closed in February 2007 with total commitments of $550 million (plus $22 million of co-investments committed by partners and individuals affiliated with SVLS).

As investments are made, links to portfolio companies will be placed below.



Affinium Pharmaceuticals : Canada

First investment: 2007 - Early Stage

Affinium is a pharmaceutical company focused on the clinical development of antibacterials.

---

EUSA Pharma : US

First investment: 2007 - Early Stage

A specialty pharmaceutical company focused on developing and marketing innovative products for the worldwide hospital market.

---